Dow Down0.06% Nasdaq Up1.04%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
4.80 Up 0.22(4.80%) 2:33PM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
Northwest Biotherapeutics, Inc.
4800 Montgomery Lane
Suite 800
Bethesda, MD 20814
United States - Map
Phone: 240-497-9024
Website: http://www.nwbio.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:9

Business Summary 

Northwest Biotherapeutics, Inc., a development stage biotechnology company, discovers and develops immunotherapy products to treat cancers in the United States and internationally. It is involved in the development of DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer. The company’s products include DCVax-L, which is under Phase III brain cancer trial for treating brain and ovarian cancer; DCVax-Direct that is under Phase I/II clinical for various types of inoperable solid tumor cancers; and DCVax-Prostate for late stage hormone independent prostate cancer. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Northwest Biotherapeutics, Inc.

Key Executives 
 PayExercised
Ms. Linda F. Powers J.D., 59
Chairperson, Chief Exec. Officer, Pres, Chief Financial Officer and Principal Accounting Officer
360.00K0.00
Dr. Alton L. Boynton Ph.D., 70
Founder, Chief Scientific Officer, Sec. and Director
295.00K0.00
Dr. Marnix L. Bosch Ph.D., MBA, 54
Chief Technical Officer
325.00K0.00
Mr. Leslie J. Goldman , 69
Sr. VP of Bus. Devel.
348.00K0.00
Dr. Anthony E. Maida III, MA, MBA, Ph.D., 62
Sr. VP of Clinical Research
300.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders